LegoChem Biosciences, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was KRW 5,218.65 million compared to KRW 6,391.19 million a year ago. Net loss was KRW 19,765.16 million compared to KRW 8,496.28 million a year ago. Basic loss per share from continuing operations was KRW 746 compared to KRW 135 a year ago. Diluted loss per share from continuing operations was KRW 746 compared to KRW 135 a year ago. Basic loss per share was KRW 746 compared to KRW 135 a year ago.
For the nine months, negative sales was KRW 0.0004 million compared to KRW 0.00029 million a year ago. Net loss was KRW 57,551.95 million compared to KRW 19,590.62 million a year ago. Basic loss per share from continuing operations was KRW 2,179 compared to KRW 807 a year ago. Diluted loss per share from continuing operations was KRW 2,179 compared to KRW 807 a year ago. Basic loss per share was KRW 2,179 compared to KRW 807 a year ago.